Pros | ![]() 5Y returns in the top 25% of the category. ![]() 3Y returns in the top 25% of the category. ![]() Beats FD returns for both 3Y & 5Y duration. | ![]() 5Y returns in the top 25% of the category. ![]() 3Y returns in the top 25% of the category. ![]() Larger AUM within category. | ||
Cons | - | - |
INDMoney rank | 1/8 | 3/8 | ||
Category,Subcateogry | Equity,Sector - Healthcare | Equity,Sector - Healthcare | ||
Fund Age | 12 Years | 7 Years | ||
Fund Size | 3849 Cr | 5728 Cr | ||
Min Investment | SIP ₹500 Lumpsum ₹5000 | SIP ₹100 Lumpsum ₹5000 | ||
Expense Ratio | 0.9% | 1.06% | ||
Exit Load | 0.5% | 1% | ||
Benchmark Index | BSE Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 32 | 41 | ||
Top 5 Holdings | Sun Pharmaceuticals Industries Ltd (12.73%) Divi's Laboratories Ltd (7.39%) Max Healthcare Institute Ltd Ordinary Shares (6.4%) Lonza Group Ltd ADR (4.81%) Cipla Ltd (4.77%) | Sun Pharmaceuticals Industries Ltd (12.66%) Dr Reddy's Laboratories Ltd (9.66%) Divi's Laboratories Ltd (9.03%) Cipla Ltd (7.85%) Aurobindo Pharma Ltd (6.34%) | ||
No of Sectors | 2 | 3 | ||
Top 3 Sectors | Health (93.74%) Basic Materials (6.26%) | Health (94.88%) Basic Materials (3.81%) Financial Services (1.31%) | ||
Equity % | 96.08% | 96.99% | ||
Debt % | - | - | ||
P/E | 43.88 | 31.57 | ||
P/B | 6.22 | 4.13 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | 1.43% | 0.99% | ||
3-Month Return | 7.96% | 12.98% | ||
6-Month Return | 1.58% | 3.47% | ||
1-Year Return | 18.94% | 18.56% | ||
3-Year Return | 29.51% | 30.01% | ||
5-Year Return | 25.33% | 25.57% |
Sharpe | 1.57 | 1.43 | ||
Alpha | 5.16 | 3.56 | ||
Beta | 0.84 | 0.94 | ||
Standard Deviation | 13.71 | 15.37 | ||
Information Ratio | 0.71 | 1.04 |
Description | SBI Healthcare Opportunities Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Tanmaya Desai | Dharmesh Kakkad |